Company / Return on Assets (ROA)
Coherus Oncology, Inc. Return on Assets (ROA) History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
22.0%
FY2019
5-year range
-210.5% / 22.0%
FY2015-FY2019
Trend
+110.4%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) returned to growth in FY2019 after 4 years of decline, reaching 22.0%.
Based on SEC 10-K filings.
22.0% in FY2019 with a 5-year CAGR of +39.6%.
Improved from -146.5% to 22.0% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +70.8pp
- 5-Year Change
- +39.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, return on assets (roa) increased 110.4% year-over-year.
- Lowest return on assets (roa) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2019 | 22.0% | +110.4% |
| FY2018 | -210.5% | -43.7% |
| FY2017 | -146.5% | -200.0% |
| FY2016 | -48.8% | -93.3% |
| FY2015 | -25.3% | -43.1% |
| FY2014 | -17.6% | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026